Popular Topics
Oral Micronized Progesterone for Perimenopausal Hot Flushes
CeMCOR is now recruiting participants for this CIHR-funded randomized controlled trial to test whether oral
micronized progesterone is more effective than placebo as therapy for
hot flushes and night sweats in perimenopausal women.
The study is open to perimenopausal women 35 to 57 (who have menstruated within the past 12 months) with moderate-to-severe hot flushes (4 per day) and/or night sweats (waking twice weekly). Participants should not have used estrogen, progesterone, progestin or hormonal birth control within the past 6 months.
To obtain more details about your eligibility click here or call or e-mail study coordinator Andrea Cameron at the contact below.
Phone: (604)875-5960
E-mail: hotflush-study@interchange.ubc.ca
We Rely On Your Support
If you find these materials helpful, and if you are able, please consider making a donation to cover our costs and support the research and education objectives of the Centre for Menstrual Cycle and Ovulation Research.
